ScholarLens Back to search
2016•BloodOpen access

The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia

Guillaume Olombel, Estelle Guérin, Julien Guy, Jean‐Yves Perrot, Florent Dumézy, Adrienne de Labarthe, Jean Bastié, Ollivier Legrand, Emmanuel Raffoux, Adriana Pleșa, Orianne Wagner‐Ballon, Édouard Cornet, Véronique Salaün, Claude Preudhomme, Xavier Thomas, Cécile Pautas, Sylvain Chantepie, Pascal Turlure, Sylvie Castaigné, Hervé Dombret, Jean Feuillard

Open full text 70 citations

Abstract

HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they are published or not.The documents may come from teaching and research institutions in France or abroad, or from public

Open-access reader

About this research paper

What this paper is about

HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they are published or not.The documents may come from teaching and research institutions in France or abroad, or from public

Why it matters

OpenAlex reports 70 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they are published or not.The documents may come from teaching and research institutions in France or abroad, or from public

Key concepts: Gemtuzumab ozogamicin, Calicheamicin, Immunoconjugate, Myeloid leukemia, CD33, Medicine, Monoclonal antibody, Leukemia

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia — Research Paper | ScholarLens